<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/232670-process-for-the-purification-of-gabapentin by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:16:54 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 232670:PROCESS FOR THE PURIFICATION OF GABAPENTIN</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">PROCESS FOR THE PURIFICATION OF GABAPENTIN</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>A process for the preparation of gabapentin which comprises the passage of a gabapentin inorganic salt through a strong cationic ionic exchange resin, the elution of gabapentin fixed on the column, the concentration of the resultant solution and the cristallization from organic solvent, characterized in that the elution of gabapentin fixed on the column is carried out by using an ammonia and alkaline hydroxide aqueous solution.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br>
"PROCESS FOR THE PURIFICATION OF GABAPENTIN"<br>
The present invention relates to a process for the preparation of gabapentin.<br>
Gabapentin   (The   Merck  Index  XII  Ed.,  page   733,  No.   4343)   is   a  known  drug<br>
endowed with anti-epilectic activity described for the first time by Warner Lambert<br>
Co. in the US patent 4,024,175.<br>
In  the  literature  several  processes  for  the  preparation  of gabapentin  are  reported<br>
(see for example the US patents 4,024,175, 5,068,413 and 5,091,567).<br>
Substantially,   all   these   methods   foresee   a   final   step   of  purification   by   column<br>
chromatography     of    an     aqueous     solution    of    a     gabapentin     salt,     generally<br>
hydrochloride, through a weak basic ionic exchange resin.<br>
In the patent application PCT No. WO 02/34709 in the name of the same Applicant,<br>
a process of purification that foresees the chromatography of an aqueous solution of<br>
gabapentin    hydrochloride    through    strong    cationic    ionic    exchange    resins    is<br>
described.<br>
The  process  described  in  the  above cited  PCT patent  application  is  very efficient<br>
and it allows to obtain, after concentration of the eluate and crystallization, a high<br>
pure  product,   almost   completely  free   from  the   corresponding   lactam  which  is   a<br>
substance   endowed   with   a   certain   toxicity   (Von   A.   Enders   et   al.,   Arzneimittel<br>
Forschung, 10, (1960), 243-250).<br>
During the chromatographic phase on cationic resin, gabapentin is fixed to the resin<br>
allowing  the  other substances  to  percolate,  in particular organic  impurities  coming<br>
from the synthetic process.<br>
Gabapentin is  then eluted with an ammonia aqueous  solution with a concentration<br>
around 3-4% and then with water.<br>
The   fractions   containing  gabapentin  are  collected  and   concentrated  under  vacuum<br>
till obtaining a solid residue from which gabapentin is isolated by crystallization from<br>
organic solvents, preferably alcoholic solvents.<br>
The   above   described  process   itself appears   [to  be]   optimum  with   regard  to  the<br>
purification of gabapentin.<br><br>
Nevertheless,  said process  needs  a high  amount of ammonia  solution  (about 4500<br>
liters at 3% for 350 Kg of gabapentin). The ammonia solution must then be drained<br>
by a biological draining system and this results both in an increase in costs and in a<br>
prolonged utilization of the draining system itself.<br>
We have now found a variation to the process described in the patent application<br>
PCT No. WO 02/34709 which allows to considerably reduce the amount of the used<br>
ammonia  solution  obtaining  at  the  same  time  an  equally  pure  product  and  with<br>
substantially the same yields.<br>
Said variation consists in eluting gabapentin fixed on the strong cationic resin with<br>
an ammonia and alkaline hydroxyde aqueous solution.<br>
Therefore,   object   of  the   present   invention   is   a   process   for   the   preparation   of<br>
gabapentin which  comprises  the  passage  of a  gabapentin  inorganic  salt  through  a<br>
strong cationic ionic exchange resin, the elution of gabapentin fixed on the column,<br>
the   concentration   of  the   resultant   solution   and   the   crystallization   from   organic<br>
solvent, characterized by the fact that the elution of gabapentin fixed on the column<br>
is carried out by using an ammonia and alkaline hydroxide aqueous solution.<br>
Preferably, for economic reasons purely, the alkaline hydroxide is sodium hydroxide.<br>
Not   limitative   examples   of  strong   cationic   resins   useful   in   the   process   of  the<br>
invention are IRA120, DIAION SK1B and IMAC HP1110.<br>
The  amount of alkaline  hydroxide must not  exceed the molar amount of cationic<br>
resin used in order to minimize the amount of alkaline hydroxide which elutes with<br>
gabapentin forming an alkaline salt of gabapentin.<br>
Preferably,  the  concentration  of NH3  in  the  elution  solutions  is  around  3-4%  by<br>
weight and the concentration of NaOH around 7% by weight. The ratio between NH3<br>
and NaOH is preferably from 1:1 to 1:2.<br>
At the end of elution the column is washed with demineralised water.<br>
Practically, the method object of the invention allows to substitute a relevant amount<br>
(about 60-70%) of ammonia with sodium hydroxide and this results in a significant<br>
reduction of draining time and costs of the ammonia solution.<br><br>
As  further collateral  advantage,  the  eluate  volume  is  reduced  of about  20%  with<br>
further reduction of costs and time.<br>
Thus, for example, if 4500 1 of an aqueous solution of NH3 at 3% every 350 Kg of<br>
gabapentin   by   the   method   described   in   the   patent   application   PCT   No.   WO<br>
02/34709 were necessary, 4100 1 of an aqueous solution of NH3 at 3% (1400 1) and<br>
a solution of NaOH at 7% (2700 1) for the same amount of gabapentin by the method<br>
object of the present invention are sufficient.<br>
The   eluate   also   contains   a   small   amount   of alkaline   hydroxide   in  the   form   of<br>
gabapentin salt,  for example  sodium salt,  which may possess  a destabilizing effect<br>
on gabapentin.<br>
Nevertheless, the elimination of the sodium salt can be realized by adding a small<br>
amount of mineral acid to the solution, preferably HC1.<br>
HC1 (a diluted aqueous solution) can be directly added in the eluate or after having<br>
concentrated it at about 50% by distillation i.e after having substantially removed the<br>
ammonia.<br>
The  subsequent crystallization  according to known techniques removes  a great part<br>
of the  chlorides  added,  giving gabapentin  containing chlorides between 30  and  70<br>
ppm i.e. in line with pharmacopoeia requirements (less than 100 ppm).<br>
In a practical embodiment the process of the invention comprises fixing gabapentin<br>
on a strong cationic resin, washing with water in order to remove the inorganic acid,<br>
eluting  the   resin  with   an   ammonia   and   sodium  hydroxide   aqueous   solution   and<br>
washing   the   resin   with   demineralised   water,   collecting   the   fractions   containing<br>
gabapentin,   concentrating   the   solution   till   about   50%,   neutralizing   the   present<br>
sodium   salt   of  gabapentin   with   HC1,   further  concentrating   till   obtaining   a  thick<br>
residue, crystallizing gabapentin from alcoholic solvents.<br>
For better illustrating the present invention the following examples are now given.<br>
Example 1 In a glass column (diameter 45 mm, height 450 mm) endowed with porous septum, 500 ml of suitably activated and regenerated resin Diaion SK1B were charged.<br><br>
A solution of gabapentin hydrochloride (652 g of solution at 14.48% equal to 94.4 g<br>
of gabapentin) was eluted through the column.<br>
The column was then washed eluting with demineralised water about 1500 g till pH<br>
7.<br>
Then, a mixture (720 g) of an ammonia solution at 3% (240 g) and a solution of<br>
NaOH at 7% (480 g) was eluted through the column.<br>
At the end the column was eluted with demineralised water till pH 7 (about 1500 g).<br>
The  fractions  of eluate  containing  gabapentin  were  collected  obtaining  a  solution<br>
(2171 g) containing gabapentin (4.25%, 92.3 g).<br>
To the solution,  23.4 g of HC1 solution at 3.99% (equal to 0.934 g of HC1) was<br>
added.<br>
The  solution  was  then  concentrated  under  vacuum  at   a  temperature  below  40°C<br>
obtaining a crude (91.2 g) containing gabapentin at 97.6%.<br>
In  a  500 ml  reactor  under  nitrogen crude  gabapentin  (70  g),  demineralised water<br>
(34.7 g) and methanol (43.7 g) were charged.<br>
The   suspension   was   heated   at   50°C   for   30  minutes   and   then  isopropyl   alcohol<br>
(180.5 g) was added drop wise in 30 minutes.<br>
The mixture was kept at 50°C for further 30 minutes and then it was cooled at 25 °C<br>
in 2 hours and at -5°C in a further hour, keeping this temperature for further 2 hours.<br>
The solid was filtered and washed on the filter with isopropyl alcohol cooled at -5°C.<br>
After drying in oven at 45 °C, gabapentin (64 g) was obtained with purity higher than<br>
99%, lactam under 0.01% and 69 ppm of chlorides (expressed as CI").<br><br><br><br><br><br><br><br>
Claims<br>
1)	A process for the preparation of gabapentin which comprises the passage of a<br>
gabapentin inorganic salt through a strong cationic ionic exchange resin, the elution<br>
of gabapentin fixed on the column, the concentration of the resultant solution and<br>
the cristallization from organic solvent, characterized in that the elution of<br>
gabapentin fixed on the column is carried out by using an ammonia and alkaline<br>
hydroxide aqueous solution.<br>
2)	A process according to claim 1 wherein the alkaline hydroxide is NaOH.<br>
3)	A process according to claim 1 wherein the ammonia and NaOH aqueous<br>
solution is obtained by mixing an ammonia aqueous solution at 3-4% with a sodium<br>
hydroxide aqueous solution at 7-8%.<br>
4)	A process according to claim 1 wherein the gabapentin sodium salt that is present<br>
in the eluate is neutralized with an aqueous solution of HC1.<br>
5)	A process according to claim 1 which comprises fixing gabapentin on a strong<br>
cationic resin, washing with water, eluting the resin with an ammonia and sodium<br>
hydroxide aqueous solution and washing the resin with demineralised water,<br>
collecting the fractions containing gabapentin, concentrating the solution till about<br>
50%, neutralizing by HC1 the present gabapentin sodium salt, further concentrating<br>
till a thick residue, crystallizing gabapentin from alcoholic solvents.<br><br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1IGFic3RyYWN0LWR1cGxpY2F0ZS5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005 abstract-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1IGNsYWltcy1kdXBsaWNhdGUucGRm" target="_blank" style="word-wrap:break-word;">3462-chenp-2005 claims-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1IGRlc2NyaXB0aW9uIChjb21wbGV0ZSktZHVwbGljYXRlLnBkZg==" target="_blank" style="word-wrap:break-word;">3462-chenp-2005 description (complete)-duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWNsYWltcy5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-claims.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWNvcnJlc3BvbmRuZWNlLW90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-correspondnece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWRlc2NyaXB0aW9uKGNvbXBsZXRlKS5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-description(complete).pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWZvcm0gMTgucGRm" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-form 18.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-form 3.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LWZvcm0gNS5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-form 5.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=MzQ2Mi1jaGVucC0yMDA1LXBjdC5wZGY=" target="_blank" style="word-wrap:break-word;">3462-chenp-2005-pct.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="232669-ph-sensitive-polymer.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="232671-a-penetration-resistant-material.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>232670</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>3462/CHENP/2005</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>13/2009</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>27-Mar-2009</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>20-Mar-2009</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>20-Dec-2005</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>ZAMBON GROUP S.P.A</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>Via della Chimica, 9, I-36100 Vicenza,</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>COTARCA, Livius</td>
											<td>Via Mercato 18, I-33052 Cervignano del Friuli,</td>
										</tr>
										<tr>
											<td>2</td>
											<td>GIOVANETTI, Roberto</td>
											<td>Via L. Da Vinci 121, I-36015 Schio,</td>
										</tr>
										<tr>
											<td>3</td>
											<td>NICOLI, Andrea</td>
											<td>Via Monzanbano, 50, I-36100 Vicenza,</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>C07C227/00</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>PCT/EP04/06513</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td>2004-06-17</td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td>MI2003A001247</td>
									<td>2003-06-20</td>
								    <td>Italy</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/232670-process-for-the-purification-of-gabapentin by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 13:16:55 GMT -->
</html>
